Chapel Hill, NC, United States of America

Christopher Mack

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Christopher Mack in Smooth Muscle Cell Modulation

Introduction

Christopher Mack is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of molecular biology, particularly in the modulation of smooth muscle cells (SMC). His innovative work has the potential to impact therapeutic treatments for various disorders.

Latest Patents

Christopher Mack holds a patent titled "Compositions and methods for modulating expression within smooth muscle cells." This invention focuses on the use of promoters, enhancers, and regulatory elements that direct expression within SMC. The patent details the development of expression vectors, host cells, and transgenic animals that can control the expression of specific genes related to SMC. The methods outlined in the patent also provide a framework for screening candidate molecules that can act as agonists or antagonists for disorders involving SMC.

Career Highlights

Mack's career is marked by his dedication to advancing scientific knowledge and therapeutic applications. His work at Setagon, Inc. has positioned him as a key figure in the research and development of innovative solutions for SMC-related diseases. His patent reflects his commitment to addressing complex biological challenges through innovative methodologies.

Collaborations

Christopher Mack has collaborated with notable colleagues, including Gary Owens and Randall Blank. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the field.

Conclusion

Christopher Mack's contributions to the modulation of smooth muscle cells exemplify the impact of innovative thinking in scientific research. His patent and collaborative efforts highlight the importance of advancing therapeutic options for SMC-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…